To investigate whether the combination of 5-FU and Tubastatin A is effective in targeting colon cancer stem cells and tumor growth, in vitro drug resistance and in vivo mouse xenograft assays were performed using sorted CD44+/CD133+ and CD44−/CD133− DLD1 cells. The gene discussed is PROM1; the disease is malignant colon neoplasm.